Abstract Body

The Ending the HIV Epidemic (EtHE) initiative targets a 75% decline in HIV incidence in 5 years and a 90% decline in 10 years. Available estimates for U.S. population incidence are derived from a CD4 depletion model developed by investigators at the Center for Disease Control. We evaluated this model in a cohort with well characterized estimated dates of incident infection.

We evaluated 702 antiretroviral (ART)-naïve, newly HIV-1 diagnosed individuals with acute and early HIV infection enrolled to the San Diego Primary Infection Resource Consortium (PIRC) between June 1996 and July 2019. Clinical data, including CD4 counts were collected at baseline (Day 0), weeks 4, 12, 24, and every 24 weeks thereafter. Persons with acute infection (antibody neg/HIV nucleic acid test pos) had additional CD4 and VL measures at weeks 2 and 8. We calculated an estimated date of infection (EDI) using previously characterized serologic and virologic criteria. We compared this PIRC EDI with the EDI generated by the CD4 model.

Of the 702 newly HIV diagnosed individuals (age 16-71), 234 (33.3%) were diagnosed during acute infection, 468 (66.7%) during recent infection; 90.8% estimated by limiting-antigen (LAg) avidity assay in combination with viral load information (PIRC EDI model) and 9.2% by interval HIV seroconversion (documented negative HIV serology in prior year). The PIRC EDI was weakly correlated with the CD4 model EDI (R2 = 0.017) (Figure). Among the 159 (23%) PIRC participants with follow-up CD4 data for ≥1 year prior to starting ART, we also used the pre-ART CD4 to calculate the CD4 model EDI (i.e., sampled during chronic infection).  The pre-ART CD4 EDI also was weakly correlated with the PIRC EDI (R2=0.00058). When using the PIRC EDI as the gold standard, the sensitivity of the CD4 model was 51% (95% CI 47%-55%) and specificity was 60% (95% CI 52%-67%).

The CD4 depletion model did not correctly identify persons with incident infection and did not differentiate persons with incident and chronic infections. The CD4 depletion model is not an appropriate model for monitoring incidence trends among smaller sample sizes, such are likely to be represented within the highest burden EtHE jurisdictions. Alternative strategies are needed, including scale-up of objective measures of HIV incidence, to measure the primary outcome of the EtHE initiative.